What If Your Retinitis Pigmentosa Genetic Test is Negative?
At a Glance
A negative genetic test does not mean you were misdiagnosed with retinitis pigmentosa. Current tests only find the exact genetic cause in about half to three-quarters of patients. Your doctor will continue managing your symptoms, and you can join patient registries for future testing updates.
In this answer
3 sections
If your eye doctor has diagnosed you with retinitis pigmentosa based on the appearance of your retina and your symptoms, a negative genetic test does not mean you were misdiagnosed. A clinical diagnosis is based on what the doctor sees during an exam, while a genetic test looks for the specific “typo” in your DNA that caused it. Because current genetic testing identifies the exact genetic cause in only about 50% to 75% of patients [1][2], it is entirely possible to have all the classic signs of RP but not receive a positive genetic match today. Importantly, a negative genetic test does not change your overall clinical care—your doctor will still monitor your vision and manage your symptoms exactly the same way.
Why Did the Test Come Back Negative?
There are several reasons why your genetic test may not have found the exact cause of your condition:
- Undiscovered genes: Retinitis pigmentosa is incredibly complex. There are over 70 known genes that cause the non-syndromic forms of the condition [3], and scientists continue to discover new ones [4][5]. The gene responsible for your vision loss may simply not have been discovered or added to the testing panels yet.
- Complex mutations: Standard genetic tests are excellent at finding simple spelling errors in your DNA. However, they can miss more complex structural changes, such as missing chunks of DNA, called copy number variations, or errors in how the DNA is read, known as splice defects [6][7].
- Atypical conditions: In some cases, a negative result might prompt your doctor to reconsider whether your symptoms are caused by a different genetic condition that mimics RP, or a systemic syndrome—such as Usher syndrome, where mild hearing loss might develop alongside vision changes [8].
Understanding “Variants of Uncertain Significance” (VUS)
Sometimes, a genetic test doesn’t come back clearly positive or negative. Instead, it flags a Variant of Uncertain Significance (VUS). A VUS means the laboratory found a change in your DNA, but there is not yet enough scientific evidence to know if this specific change causes the disease or is just a harmless natural variation [9].
Working with a genetic counselor (a medical professional specializing in genetics) before and after testing is highly recommended. If you have a VUS, they might suggest testing other family members [10]. Checking to see if the same DNA change appears in relatives who also have RP can help researchers determine if the VUS is truly responsible for your condition [11][10].
Actionable Next Steps: Joining a Patient Registry
Falling into the “unsolved” genetic bucket can feel frustrating, but you are not out of options. One of the most important steps you can take is to join an inherited retinal disease (IRD) registry, such as the VENTURE registry or My Retina Tracker [12][13].
Registries are secure databases where patients share their clinical and genetic information with researchers [14]. Joining a registry is vital for a few reasons:
- Re-testing alerts: As genetic knowledge expands and testing technology improves, registries can notify you when new testing panels become available that might identify your specific mutation [15]. In addition to relying on registry alerts, it is a good idea to proactively check in with your genetic counselor or ophthalmologist every 1 to 3 years. Often, future testing simply requires a re-analysis of the DNA data already on file, rather than a new blood or saliva draw.
- Research participation: By contributing your anonymized data, you help scientists discover the missing RP genes, moving the science forward for everyone [16].
- Clinical trial matching: If a new treatment or gene therapy is developed for your clinical profile, registries provide a direct pathway for researchers to find and recruit eligible patients [13].
Common questions in this guide
Does a negative genetic test mean I don't have retinitis pigmentosa?
Why didn't my genetic test find the cause of my vision loss?
What is a Variant of Uncertain Significance (VUS) on my genetic report?
What should I do next if my retinitis pigmentosa genetic test is negative?
Should I be tested for other conditions if my RP gene test is negative?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Were there any Variants of Uncertain Significance (VUS) found on my genetic test report?
- 2.What specific type of genetic test was used, and would a broader test like whole genome sequencing be appropriate for me?
- 3.Can we set a reminder for every 1 to 3 years to re-evaluate my genetic test results or re-analyze my DNA data?
- 4.Do my current clinical symptoms suggest any other conditions or syndromes we should be looking out for?
- 5.Are there any inherited retinal disease registries you recommend I join, and can you help me upload my records?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (16)
- 1
Gene panel sequencing in Brazilian patients with retinitis pigmentosa.
Costa KA, Salles MV, Whitebirch C, et al.
International journal of retina and vitreous 2017; (3()):33 doi:10.1186/s40942-017-0087-6.
PMID: 28912962 - 2
NGS-based Molecular diagnosis of 105 eyeGENE(®) probands with Retinitis Pigmentosa.
Ge Z, Bowles K, Goetz K, et al.
Scientific reports 2015; (5()):18287 doi:10.1038/srep18287.
PMID: 26667666 - 3
Autosomal Dominant Retinitis Pigmentosa.
Tsang SH, Sharma T
Advances in experimental medicine and biology 2018; (1085()):69-77 doi:10.1007/978-3-319-95046-4_15.
PMID: 30578488 - 4
von Willebrand factor A domain containing 8 (VWA8)- associated retinitis pigmentosa: description of a novel case and expansion of the phenotype.
Chacon-Camacho OF, Arce-González R, Martínez-Aguilar A, Zenteno JC
International ophthalmology 2025; (45(1)):282 doi:10.1007/s10792-025-03657-5.
PMID: 40638000 - 5
Genetic and bioinformatic analysis of RHO and PRPH2 variants in north Indian retinitis pigmentosa patients.
Bhardwaj A, Phogat J, Yadav M, et al.
Japanese journal of ophthalmology 2026; (70(2)):429-440 doi:10.1007/s10384-025-01262-8.
PMID: 40880019 - 6
Pseudodominant inheritance of retinitis pigmentosa in a family with mutations in the Eyes Shut Homolog (EYS) gene.
Di Iorio E, Adamo GG, Sorrentino U, et al.
Scientific reports 2024; (14(1)):18580 doi:10.1038/s41598-024-69640-9.
PMID: 39127808 - 7
Improved Diagnosis of Inherited Retinal Dystrophies by High-Fidelity PCR of ORF15 followed by Next-Generation Sequencing.
Li J, Tang J, Feng Y, et al.
The Journal of molecular diagnostics : JMD 2016; (18(6)):817-824 doi:10.1016/j.jmoldx.2016.06.007.
PMID: 27620828 - 8
Genetic testing in patients with retinitis pigmentosa: Features of unsolved cases.
Birtel J, Gliem M, Oishi A, et al.
Clinical & experimental ophthalmology 2019; (47(6)):779-786 doi:10.1111/ceo.13516.
PMID: 30977268 - 9
PRPH2 mutation update: In silico assessment of 245 reported and 7 novel variants in patients with retinal disease.
Peeters MHCA, Khan M, Rooijakkers AAMB, et al.
Human mutation 2021; (42(12)):1521-1547 doi:10.1002/humu.24275.
PMID: 34411390 - 10
Functional Evaluation of Splicing for Variants of Uncertain Significance in Patients with Inherited Retinal Diseases.
Mauro-Herrera M, Chiang J, Radojevic B, Bennett LD
Genes 2021; (12(7)) doi:10.3390/genes12070993.
PMID: 34209753 - 11
Leveraging splice-affecting variant predictors and a minigene validation system to identify Mendelian disease-causing variants among exon-captured variants of uncertain significance.
Soens ZT, Branch J, Wu S, et al.
Human mutation 2017; (38(11)):1521-1533 doi:10.1002/humu.23294.
PMID: 28714225 - 12
Victorian evolution of inherited retinal diseases natural history registry (VENTURE study): Rationale, methodology and initial participant characteristics.
Britten-Jones AC, O'Hare F, Edwards TL, et al.
Clinical & experimental ophthalmology 2022; (50(7)):768-780 doi:10.1111/ceo.14110.
PMID: 35621151 - 13
An optometrist's guide to the top candidate inherited retinal diseases for gene therapy.
O'Hare F, Edwards TL, Hu ML, et al.
Clinical & experimental optometry 2021; (104(4)):431-443 doi:10.1080/08164622.2021.1878851.
PMID: 33689629 - 14
Expanding the Mutation Spectrum for Inherited Retinal Diseases.
Lynn J, Huang SJ, Trigler GK, et al.
Genes 2024; (16(1)) doi:10.3390/genes16010032.
PMID: 39858579 - 15
Predictive value of genetic testing for inherited retinal diseases in patients with suspected atypical autoimmune retinopathy.
Stanwyck LK, Place EM, Comander J, et al.
American journal of ophthalmology case reports 2019; (15()):100461 doi:10.1016/j.ajoc.2019.100461.
PMID: 31193260 - 16
18-Years of single-centre DNA testing in over 7000 index cases with inherited retinal dystrophies and optic neuropathies.
Kiel C, Biasella F, Stöhr H, et al.
Scientific reports 2024; (14(1)):25529 doi:10.1038/s41598-024-77014-4.
PMID: 39462066
This page provides general information about interpreting negative genetic test results for retinitis pigmentosa. It is not a substitute for professional medical advice, diagnosis, or interpretation by your ophthalmologist or genetic counselor.
Get notified when new evidence is published on Retinitis pigmentosa.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.